Qube Research & Technologies Ltd - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$491,165
-89.5%
2,265
-89.1%
0.00%
-92.9%
Q3 2022$4,680,000
+705.5%
20,808
+308.4%
0.03%
+300.0%
Q2 2021$581,0005,0950.01%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
ARCH Venture Management, LLC 2,912,872$369,323,00052.78%
Pivotal bioVenture Partners Investment Advisor LLC 852,708$108,115,00051.15%
Sofinnova Investments, Inc. 1,953,077$247,631,00018.79%
Nan Fung Group Holdings Ltd 234,811$29,772,00014.12%
Sands Capital Ventures, LLC 267,895$33,966,0007.10%
Logos Global Management LP 340,000$43,109,0005.59%
DAFNA Capital Management LLC 82,053$10,403,0002.71%
Ghost Tree Capital, LLC 60,000$7,607,0001.65%
CATALYST PRIVATE WEALTH, LLC 24,976$3,167,0001.58%
Eventide Asset Management 748,000$94,839,0001.49%
View complete list of KARUNA THERAPEUTICS INC shareholders